glutathione therapy for parkinson' Safety of AADC Gene Moderately Advanced Parkinson Disease Frontiers | Microbiome-based therapies for
Description
19, reactions 2 and 4)
William Schaffner, M.D., professor of preventive medicine and infectious diseases at Vanderbilt University School of Medicine, says one jab instead of two may also appeal to more people and could potentially boost the number of individuals getting vaccinated.
2011 doi: 10.1172/JCI43144
Fenlon, D
